Cargando…
Coenzyme Q(10) Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials
Evidence from randomized controlled trials (RCTs) suggests that coenzyme Q(10) (CoQ(10)) can regulate adipokine levels to impact inflammation and oxidative stress in conditions of metabolic syndrome. Here, prominent electronic databases such as MEDLINE, Cochrane Library, and EMBASE were searched for...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247332/ https://www.ncbi.nlm.nih.gov/pubmed/32375340 http://dx.doi.org/10.3390/ijms21093247 |
_version_ | 1783538133392949248 |
---|---|
author | Dludla, Phiwayinkosi V. Orlando, Patrick Silvestri, Sonia Marcheggiani, Fabio Cirilli, Ilenia Nyambuya, Tawanda M. Mxinwa, Vuyolwethu Mokgalaboni, Kabelo Nkambule, Bongani B. Johnson, Rabia Mazibuko-Mbeje, Sithandiwe E. Muller, Christo J. F. Louw, Johan Tiano, Luca |
author_facet | Dludla, Phiwayinkosi V. Orlando, Patrick Silvestri, Sonia Marcheggiani, Fabio Cirilli, Ilenia Nyambuya, Tawanda M. Mxinwa, Vuyolwethu Mokgalaboni, Kabelo Nkambule, Bongani B. Johnson, Rabia Mazibuko-Mbeje, Sithandiwe E. Muller, Christo J. F. Louw, Johan Tiano, Luca |
author_sort | Dludla, Phiwayinkosi V. |
collection | PubMed |
description | Evidence from randomized controlled trials (RCTs) suggests that coenzyme Q(10) (CoQ(10)) can regulate adipokine levels to impact inflammation and oxidative stress in conditions of metabolic syndrome. Here, prominent electronic databases such as MEDLINE, Cochrane Library, and EMBASE were searched for eligible RCTs reporting on any correlation between adipokine levels and modulation of inflammation and oxidative stress in individuals with metabolic syndrome taking CoQ(10). The risk of bias was assessed using the modified Black and Downs checklist, while the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool was used to evaluate the quality of evidence. Results from the current meta-analysis, involving 318 participants, showed that CoQ(10) supplementation in individuals with metabolic syndrome increased adiponectin levels when compared to those on placebo (SMD: 1.44 [95% CI: −0.13, 3.00]; I(2) = 96%, p < 0.00001). Moreover, CoQ(10) supplementation significantly lowered inflammation markers in individuals with metabolic syndrome in comparison to those on placebo (SMD: −0.31 [95% CI: −0.54, −0.08]; I(2) = 51%, p = 0.07). Such benefits with CoQ(10) supplementation were related to its ameliorative effects on lipid peroxidation by reducing malondialdehyde levels, concomitant to improving glucose control and liver function. The overall findings suggest that optimal regulation of adipokine function is crucial for the beneficial effects of CoQ(10) in improving metabolic health. |
format | Online Article Text |
id | pubmed-7247332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72473322020-06-10 Coenzyme Q(10) Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials Dludla, Phiwayinkosi V. Orlando, Patrick Silvestri, Sonia Marcheggiani, Fabio Cirilli, Ilenia Nyambuya, Tawanda M. Mxinwa, Vuyolwethu Mokgalaboni, Kabelo Nkambule, Bongani B. Johnson, Rabia Mazibuko-Mbeje, Sithandiwe E. Muller, Christo J. F. Louw, Johan Tiano, Luca Int J Mol Sci Review Evidence from randomized controlled trials (RCTs) suggests that coenzyme Q(10) (CoQ(10)) can regulate adipokine levels to impact inflammation and oxidative stress in conditions of metabolic syndrome. Here, prominent electronic databases such as MEDLINE, Cochrane Library, and EMBASE were searched for eligible RCTs reporting on any correlation between adipokine levels and modulation of inflammation and oxidative stress in individuals with metabolic syndrome taking CoQ(10). The risk of bias was assessed using the modified Black and Downs checklist, while the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool was used to evaluate the quality of evidence. Results from the current meta-analysis, involving 318 participants, showed that CoQ(10) supplementation in individuals with metabolic syndrome increased adiponectin levels when compared to those on placebo (SMD: 1.44 [95% CI: −0.13, 3.00]; I(2) = 96%, p < 0.00001). Moreover, CoQ(10) supplementation significantly lowered inflammation markers in individuals with metabolic syndrome in comparison to those on placebo (SMD: −0.31 [95% CI: −0.54, −0.08]; I(2) = 51%, p = 0.07). Such benefits with CoQ(10) supplementation were related to its ameliorative effects on lipid peroxidation by reducing malondialdehyde levels, concomitant to improving glucose control and liver function. The overall findings suggest that optimal regulation of adipokine function is crucial for the beneficial effects of CoQ(10) in improving metabolic health. MDPI 2020-05-04 /pmc/articles/PMC7247332/ /pubmed/32375340 http://dx.doi.org/10.3390/ijms21093247 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dludla, Phiwayinkosi V. Orlando, Patrick Silvestri, Sonia Marcheggiani, Fabio Cirilli, Ilenia Nyambuya, Tawanda M. Mxinwa, Vuyolwethu Mokgalaboni, Kabelo Nkambule, Bongani B. Johnson, Rabia Mazibuko-Mbeje, Sithandiwe E. Muller, Christo J. F. Louw, Johan Tiano, Luca Coenzyme Q(10) Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials |
title | Coenzyme Q(10) Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials |
title_full | Coenzyme Q(10) Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials |
title_fullStr | Coenzyme Q(10) Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed | Coenzyme Q(10) Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials |
title_short | Coenzyme Q(10) Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials |
title_sort | coenzyme q(10) supplementation improves adipokine levels and alleviates inflammation and lipid peroxidation in conditions of metabolic syndrome: a meta-analysis of randomized controlled trials |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247332/ https://www.ncbi.nlm.nih.gov/pubmed/32375340 http://dx.doi.org/10.3390/ijms21093247 |
work_keys_str_mv | AT dludlaphiwayinkosiv coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT orlandopatrick coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT silvestrisonia coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT marcheggianifabio coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT cirilliilenia coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT nyambuyatawandam coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT mxinwavuyolwethu coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT mokgalabonikabelo coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT nkambulebonganib coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT johnsonrabia coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT mazibukombejesithandiwee coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT mullerchristojf coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT louwjohan coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials AT tianoluca coenzymeq10supplementationimprovesadipokinelevelsandalleviatesinflammationandlipidperoxidationinconditionsofmetabolicsyndromeametaanalysisofrandomizedcontrolledtrials |